About MEGThis author has not yet filled in any details.
So far MEG has created 4 blog entries.
Cernostics CEO Michael Hoerres said his biotech company’s presence will not just remain but grow in Pittsburgh with the Read More
Cernostics Contracts with Geisinger Health Plan to Become an In-network Provider for TissueCypher® Barrett’s Esophagus Assay
Cernostics, pioneer of the worlds’ first precision medicine test to predict future development risk of esophageal cancer from Barrett’s esophagus (BE), TissueCypher® Barrett’s Esophagus Assay, has become a participating (“in-network”) provider for Geisinger Health Plan (GHP)’s more than 550,000 plan members in Central, North Central and East Central Pennsylvania. Read More